510(k) Report

510(k) · Cleared

Cleared

PELNAC Meshed Bilayer Wound Matrix

K213498510(k) TraditionalCleared Jul 14, 2022255-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gunze Limited · KGN Wound Dressing With Animal-Derived Material (S)

Cleared on Jul 14, 2022 as substantially equivalent to K081635 (Integra Lifesciences Corp., 2008) after a 255-day review. Its family tree reaches back 5 generations to 1988.

Decided
Jul 14, 2022
Review
255 days
Class
Class U
Product code
KGN
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K881854 (1988). 13 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK881854 Sorbsan Topical Wound DressingE.G. Dick & Assoc. · 1988
  2. 4 generations backK982597 Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc. · 1998
  3. 3 generations backK993948 Sis Wound Dressing IICook Biotech, Inc. · 2000
  4. 2 generations backK021792 Bilayer Matrix Wound DressingIntegra Lifesciences Corp. · 2002 · Recalled
  5. 1 generation backK081635 Integra Meshed Bilayer Wound MatrixIntegra Lifesciences Corp. · 2008
  6. This deviceK213498 PELNAC Meshed Bilayer Wound MatrixGunze Limited · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K881854Sorbsan Topical Wound DressingE.G. Dick & Assoc.1988—
−4K982597Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc.1998—
−3K993948Sis Wound Dressing IICook Biotech, Inc.2000—
−2K021792Bilayer Matrix Wound DressingIntegra Lifesciences Corp.20021
−1K081635Integra Meshed Bilayer Wound MatrixIntegra Lifesciences Corp.2008—
0 (this device)K213498PELNAC Meshed Bilayer Wound MatrixGunze Limited2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199010
199130
199310
199810
200210
FIG. 1 — Lineage of K213498, 1988–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KGN device

  1. #1 K231325 Corplex P / Theracor P / Allacor Pscore 17.9 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K081635Integra Meshed Bilayer Wound Matrix
Summary page 4
…General & Plastic Surgery 5. Legally Marketed Predicate Device Trade Name: INTEGRA™ Meshed Bilayer Wound Matrix 510(k) No.: K081635 Manufacturer: Integra Life Sciences The predicate device has not been subject to a design related recall.…
Integra Lifesciences Corp.2008—
†K191992PELNAC Bilayer Wound MatrixGunze Limited2020—

Also cleared against K081635: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 34 years and passes through 5 companies; a new generation was cleared every 6.3 years on median.
  • 1 of the 13 ancestors has a recall of any class.
  • 4 other devices also cite its predicate K081635.

How does its category compare?

All KGN devices

KGN Wound Dressing With Animal-Derived Material (S): FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · KGN

15so far in 2026, the most since 2007

2007: 32008: 62009: 82010: 42011: 72012: 82013: 62014: 52015: 72016: 42017: 72018: 62019: 32020: 52021: 62022: 122023: 92024: 132025: 102026 (partial year): 15
2007high 15 (2026) · low 3 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KGN

162in 2025

2007: 32 days median2008: 87 days median2009: 121 days median2010: 175 days median2011: 228 days median2012: 123 days median2013: 147 days median2014: 188 days median2015: 87 days median2016: 164 days median2017: 136 days median2018: 148 days median2019: 128 days median2020: 279 days median2021: 236 days median2022: 246 days median2023: 194 days median2024: 83 days median2025: 162 days median2026 (partial year): 174 days median
2007high 279 (2020) · low 32 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KGN

3in 2018

2017: 12018: 3
2007high 3 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KGN

15in 2025

2008: 12009: 22010: 32011: 62012: 42013: 62014: 122015: 92016: 62017: 82018: 152019: 112020: 172021: 142022: 132023: 212024: 152025: 15
2007high 21 (2023) · low 0 (2007)2025

MAUDE reports naming product code KGN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200733200
200868701
2009812102
2010417503
2011722806
2012812304
2013614706
20145188012
201578709
2016416406
2017713618
20186148315
20193128011
20205279017
20216236014
202212246013
20239194021
20241383015
202510162015
2026151740—

What is it indicated for?

PELNAC® Meshed Bilayer Wound Matrix is indicated for the management of wounds including:

* partial and full-thickness wounds,

* pressure ulcers,

* venous ulcers,

* diabetic ulcers,

* chronic vascular ulcers,

* surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence),

* trauma wounds (abrasions, lacerations, partial thickness bums, and skin tears), and

* draining wounds.

The device may be used in conjunction with negative pressure wound therapy. The device is intended for one-time use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213498: PELNAC Meshed Bilayer Wound Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213498

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026